This recently listed company witnessed huge block deals today
![This recently listed company witnessed huge block deals today This recently listed company witnessed huge block deals today](https://storage.googleapis.com/5paisa-prod-storage/files/2022-03/Trending%20Company%20Post%20%281%29_15.jpg)
![resr resr](https://storage.googleapis.com/5paisa-prod-storage/files/2022-01/author.png)
Last Updated: 13th December 2022 - 01:24 pm
The healthcare services stock closed up by 1.11%.
Vijaya Diagnostic Centre Ltd, which was listed in the month of September 2021, has been trending on Dalal Street as it has rallied by over 1.11%. The scrip opened at Rs 420 and made a day’s high of Rs 428.95. As of 8th March 2022, the stock closed at Rs 424.80, up by 1.11% on the BSE.
Since its listing, the stock has witnessed a gradual downtrend. The investor- Karakoram Limited has sold about 72.9 lakh shares in the company through open market transactions at an average price of Rs 425.75. This accounts for about a 7.1% stake of the total paid-up capital.
Talking about its recent quarterly results, in Q3FY22, revenue grew by 10.91% YoY to Rs 110.78 crore from Rs 99.88 crore in Q3FY21. On a sequential basis, the top-line was down by 1.71%. PBIDT (Ex OI) was reported at Rs 47.83 crore, up by 3.03% as compared to the year-ago period and the corresponding margin was reported at 43.18%, contracting by 330 basis points YoY. PAT was reported at Rs 25.46 crore, up by 1.65% from Rs 25.05 crore in the same quarter for the previous fiscal year. The PAT margin stood at 22.98% in Q3FY22 contracting from 25.08% in Q3FY21.
Vijaya Diagnostic Centre was formed in 1981 and is one of the fastest-growing diagnostic chains in Southern India. The company offers a one-stop solution for pathology and radiology testing services. The company offers around 740 routine tests, 870 specialized pathology tests, 220 basic tests, and 320 advanced radiology tests. The stock has a 52-week high of Rs 672.50 and a 52-week low of Rs 374.65.
Trending on 5paisa
Discover more of what matters to you.
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.